Inspire Medical Systems
(NYSE) INSP
Inspire Medical Systems Financials at a Glance
Market Cap
$1.49BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$915.25M
Net Income (TTM)
$131.14M
EPS (TTM)
$4.47
P/E Ratio
11.57
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$52.00
Volume
53,108
Open
$51.21
Price
$52.00
Volume
53,108
Open
$51.21
Previous Close
$52.00
Daily Range
$50.07 - $52.49
52-Week Range
$38.91 - $147.03
Estimated Earnings Date
Aug 3, 2026
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$52.00
Volume
53,108
Open
$51.21
Previous Close
$52.00
Daily Range
$50.07 - $52.49
52-Week Range
$38.91 - $147.03
Estimated Earnings Date
Aug 3, 2026
INSP News
INSP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Inspire Medical Systems
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1,333
CEO
Timothy P. Herbert, MBA
Website
www.inspiresleep.comHeadquarters
Golden Valley, MN 55416, US
INSP Financials
Key Financial Metrics (TTM)
Gross Margin
85.78%
Operating Margin
5.61%
Net Income Margin
14.33%
Return on Equity
17.98%
Return on Capital
6.26%
Return on Assets
14.39%
Earnings Yield
8.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.49BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
28.81M
Volume
53.11K
Avg. Volume
1.16M
Financials (TTM)
Gross Profit
$785.06M
Operating Income
$51.32M
EBITDA
$80.10M
Operating Cash Flow
$136.53M
Capital Expenditure
-$39.82M
Free Cash Flow
$96.71M
Cash & ST Invst.
$283.83M
Total Debt
$29.55M
Inspire Medical Systems Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$204.58M
+1.6%
Gross Profit
$176.91M
+3.7%
Gross Margin
86.47%
N/A
Market Cap
$1.49BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.20M
N/A
Employees
1,246
N/A
Net Income
-$11.29M
-477.5%
EBITDA
$7.51M
+4.2%
Quarterly Fundamentals
Total Cash
$283.83M
-23.1%
Total Debt
$29.55M
-11.8%
Accounts Receivable
$105.09M
+13.5%
Inventory
$166.24M
+66.7%
Long Term Debt
$29.55M
-6.1%
Short Term Debt
$0.00
-100.0%
Return on Assets
14.39%
N/A
Return on Invested Capital
6.24%
N/A
Free Cash Flow
$3.12M
+120.7%
Operating Cash Flow
$12.85M
+291.7%